| Followers | 144 |
| Posts | 27604 |
| Boards Moderated | 3 |
| Alias Born | 02/07/2004 |
Monday, September 13, 2021 11:08:44 AM
In parallel RedHill's leading oral COVID-19 therapeutic, opaganib, is being evaluated
in a global Phase 2/3 study in 475 patients hospitalized with severe COVID-19,
with top-line results upcoming
Hopefully this is last time we
see the word upcoming!!!
Recent RDHL News
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
